Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A

Eur J Clin Invest. 2002 Mar:32 Suppl 1:84-90. doi: 10.1046/j.1365-2362.2002.0320s1084.x.

Abstract

Background: Chronic low-grade inflammation is associated with increased risk of vascular diseases. The source of inflammation is unknown but may well be chronic and/or repetitive infections with microorganisms. Direct infection of endothelial cells (ECs) may also be a starting point for atherogenesis by initiating endothelial procoagulant activity, increased monocyte adherence and increased cytokine production. We hypothesized that iron-mediated intracellular hydroxyl radical formation after infection is a key event in triggering the production of interleukin-6 (IL-6) by ECs in vitro.

Methods: Cultured ECs were incubated with Fe(II) and Fe(III) or infected with Chlamydia pneumoniae or influenza A/H1N1/Taiwan/1/81 for 48 and 24 h, respectively. To determine the role of iron and reactive oxygen species, cells were coincubated with the H2O2 scavenger N-acetyl-l-cysteine, with the iron chelator deferoxamine (DFO) or with the intracellular hydroxyl radical scavenger dimethylthiourea (DMTU). After the incubation periods, supernatants were harvested for IL-6 determination.

Results: Incubating ECs with Fe(II) and Fe(III) resulted in increased IL-6 production. Similarly, infection with C. pneumoniae and influenza A also induced an IL-6 response. Coincubating ECs with DFO or DMTU blocked this response. Nuclear factor-kappaB activity was increased after infection and blocked by coincubation with DFO or DMTU.

Conclusion: Cultured ECs respond to infection and iron incubation with increased production of IL-6. Iron, the generation of intracellular hydroxyl radical and NF-kappaB activity are essential in cellular activation, suggesting that reactive oxygen species generated in the Haber-Weiss reaction are essential in invoking an immunological response to infection by ECs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology
  • Cells, Cultured
  • Chlamydophila Infections / drug therapy*
  • Chlamydophila Infections / immunology
  • Chlamydophila pneumoniae*
  • Deferoxamine / pharmacology*
  • Deferoxamine / toxicity
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / immunology
  • Endothelium, Vascular / metabolism
  • Free Radical Scavengers / pharmacology*
  • Free Radical Scavengers / toxicity
  • Humans
  • Influenza A virus
  • Influenza, Human / drug therapy
  • Influenza, Human / immunology
  • Interleukin-6 / biosynthesis
  • Iron / metabolism
  • Iron Chelating Agents / pharmacology*
  • Iron Chelating Agents / toxicity
  • NF-kappa B / metabolism
  • Thiourea / analogs & derivatives*
  • Thiourea / pharmacology*
  • Thiourea / toxicity
  • Umbilical Veins / cytology

Substances

  • Antioxidants
  • Free Radical Scavengers
  • Interleukin-6
  • Iron Chelating Agents
  • NF-kappa B
  • 1,3-dimethylthiourea
  • Iron
  • Thiourea
  • Deferoxamine